Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

(NY: KVUE )

23.68 +0.71 (+3.09%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about KVUE

< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
These 2 Dow Stocks Moved Markets This Week
Bulls and bears alike looked closely at these two companies. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm – KVUE
From The Rosen Law Firm PA
Via GlobeNewswire
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Kenvue Inc. (KVUE) Investors and Encourages Investors to Contact the Firm Before December 8, 2023
From Kirby McInerney LLP
Via Business Wire
Check Out What Whales Are Doing With KVUE
Via Benzinga
KVUE Shareholders: Contact Robbins LLP About Your Rights and Remedies in the Kenvue Inc. Securities Fraud Class Action
From Robbins LLP
Via Business Wire
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous. 
Via The Motley Fool
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Why Johnson & Johnson Stock Flopped Today
Perhaps those third-quarter results weren't as impressive as they first appeared to be. 
Via The Motley Fool
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
Some things are different about J&J. But other things remain the same as they've been for a long time. 
Via The Motley Fool
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc. (KVUE)
From Glancy Prongay & Murray LLP
Via Business Wire
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Kenvue Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Initiated by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
The healthcare behemoth reported strong earnings after separating its consumer health division. 
Via The Motley Fool
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff. 
Via Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse 
Via Benzinga
Topics Earnings
Exposures Financial
KENVUE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Kenvue Inc. (KVUE)
From Law Offices of Howard G. Smith
Via Business Wire
4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation
These stocks offer attractive payouts that should rise in the future. 
Via The Motley Fool
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – KVUE
From The Rosen Law Firm PA
Via GlobeNewswire
Johnson & Johnson Stock: Is Now the Time to Sell?
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff 
Via InvestorPlace
KVUE NOTICE: ROSEN, THE FIRST FILING FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Kenvue Inc. (KVUE) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
KVUE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Kenvue Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Kenvue Inc. (KVUE) Investor Alert: Robbins LLP Informs Investors of Class Action Filed Against Kenvue Inc.
From Robbins LLP
Via Business Wire
7 High-Growth S&P 500 Stocks to Buy Now
Although industry stalwarts don’t typically offer robust profitability potential, these high-growth S&P 500 stocks might change your tune. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Kenvue Inc. (KVUE) Investors
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Kenvue Inc. (KVUE) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
KENVUE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Kenvue Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ROSEN, A LEADING NATIONAL FIRM, Encourages Kenvue Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - KVUE
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Initial Public Offering Lawsuit
Exposures Financial Legal Securities Market
< Previous 1 2
...
10 11 12 13 14 15 16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.